A detailed history of M. Kraus & CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, M. Kraus & CO holds 24,106 shares of BDX stock, worth $5.79 Million. This represents 1.88% of its overall portfolio holdings.

Number of Shares
24,106
Previous 24,939 3.34%
Holding current value
$5.79 Million
Previous $5.83 Million 0.29%
% of portfolio
1.88%
Previous 1.95%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$221.47 - $242.41 $184,484 - $201,927
-833 Reduced 3.34%
24,106 $5.81 Million
Q2 2024

Jul 10, 2024

SELL
$225.07 - $246.17 $92,278 - $100,929
-410 Reduced 1.62%
24,939 $5.83 Million
Q1 2024

Apr 10, 2024

SELL
$233.45 - $247.73 $87,076 - $92,403
-373 Reduced 1.45%
25,349 $6.27 Million
Q4 2023

Jan 10, 2024

BUY
$232.24 - $267.23 $113,565 - $130,675
489 Added 1.94%
25,722 $6.27 Million
Q3 2023

Oct 16, 2023

BUY
$254.9 - $283.59 $151,410 - $168,452
594 Added 2.41%
25,233 $6.52 Million
Q2 2023

Jul 14, 2023

SELL
$238.39 - $265.32 $64,126 - $71,371
-269 Reduced 1.08%
24,639 $6.5 Million
Q1 2023

Apr 18, 2023

SELL
$229.71 - $259.35 $24,119 - $27,231
-105 Reduced 0.42%
24,908 $6.17 Million
Q4 2022

Jan 25, 2023

BUY
$218.29 - $256.91 $120,059 - $141,300
550 Added 2.25%
25,013 $0
Q3 2022

Oct 27, 2022

BUY
$51.03 - $264.23 $4,082 - $21,138
80 Added 0.33%
24,463 $5.45 Million
Q2 2022

Jul 15, 2022

SELL
$234.74 - $275.42 $2,347 - $2,754
-10 Reduced 0.04%
24,383 $6.01 Million
Q1 2022

Apr 28, 2022

BUY
$243.64 - $270.48 $5.94 Million - $6.6 Million
24,393 New
24,393 $6.49 Million
Q4 2017

Jan 18, 2018

SELL
$189.0 - $222.64 $3.67 Million - $4.32 Million
-19,394 Closed
0 $0
Q3 2017

Oct 17, 2017

BUY
$186.89 - $198.9 $3.62 Million - $3.86 Million
19,394
19,394 $3.8 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $68.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track M. Kraus & CO Portfolio

Follow M. Kraus & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M. Kraus & CO, based on Form 13F filings with the SEC.

News

Stay updated on M. Kraus & CO with notifications on news.